Prellis Biologics Revenue and Competitors

At Prellis Biologics we are dedicated to ending the global human organ shortage by building real medical solutions that leverage the power of human cells to re-create tissues and organs for transplantation. Our ability to produce biomimetic tissue scaffolds allows us to access the power of human tissues, outside of the body, to rapidly and efficiently specific human antibodies, and albumin in the laboratory setting. Prellis Biologics, Inc was founded with the optical path for a novel form of lithography based on holographic projection sketched out in my San Francisco home office. A few months after filing the patents we were able to demonstrate that the system worked as designed and began the scale-up process, achieving over 500,000 printed voxels per second with only off-the-shelf optical equipment. This laser printing technology represents the first known example of free-form printing that significantly decouples printing resolution from speed. Since then the Prellis Team has built a high-power holographic laser printing system for biocompatible materials, companion software, and novel photo-quenching chemistry, that together, has solved the final technical hurdle in printing and producing human organ systems and tissues: building the capillaries that allow tissues to function.